Notice of DRI Healthcare Trust’s 2021 First Quarter Financial Results Earnings Call and Webcast

TORONTO, April 27, 2021 /CNW/ –¬†DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (the "Trust") will release its 2021 first quarter financial results prior to market open on Monday, May 10, 2021. Management will host a conference call to review the financial results at 8:30 a.m. ET the same morning.

All interested parties may join the conference call by dialing 647-427-7450 or 1-888-231-8191 approximately 15 minutes prior to the call to secure a line. You will be put on hold until the conference call begins.

A question-and-answer session will follow the conference call, at which time the operator will provide instructions for submitting questions.

A live audio webcast of the call will be available at http://bit.ly/DRI2021Q1. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on the Trust’s website following the call date.

The Trust’s financial statements and management’s discussion and analysis for the quarter ended March 31, 2021 will be filed on SEDAR at www.sedar.com following the release, and will also be available on the same day on the Trust’s website at www.drihealthcare.com.

About DRI Healthcare Trust

DRI Healthcare Trust provides unitholders with differentiated exposure in the fast growing pharmaceutical and biotechnology sector. Our business model is focused on managing and growing a diversified portfolio of pharmaceutical assets with the aim to deliver sustainable growth in cash royalty receipts over the long term. DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario, externally managed by its manager, DRI Capital Inc. DRI Healthcare Trust’s units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U".

SOURCE DRI Healthcare Trust

Comments are closed.